Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications

Author： Nikpoor Borzoo   Duan Qing Ling   Rouleau Guy A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.11, 2005-09, pp. : 1851-1856

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin-Converting Enzyme Inhibitors: Mechanisms of Action and Implications In Anesthesia Practice

By  

Current Pharmaceutical Design, Vol. 9, Iss. 9, 2003-04 ,pp. : 763-776

Bentham Science Publishers

Access to resources Recommend Favorite

Safety issues associated with the use of angiotensin-converting enzyme inhibitors

By Ehlers Mario R  

Expert Opinion on Drug Safety, Vol. 5, Iss. 6, 2006-11 ,pp. : 739-740

Informa Healthcare

Access to resources Recommend Favorite

Ongoing trials involving angiotensin-converting enzyme inhibitors

By Nadar Sunil   Lip Gregory YH  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1633-1643

Informa Healthcare

Access to resources Recommend Favorite

Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors

By  

Current Pharmaceutical Design, Vol. 21, Iss. 13, 2015-04 ,pp. : 1764-1775

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarction

By Salam Amar M  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 501-507

Informa Healthcare

Access to resources Recommend Favorite